Law M R, Frost C D, Wald N J
Department of Environmental and Preventive Medicine, Medical College of St Bartholomew's Hospital, London.
BMJ. 1991 Apr 6;302(6780):819-24. doi: 10.1136/bmj.302.6780.819.
To determine whether the reduction in blood pressure achieved in trials of dietary salt reduction is quantitatively consistent with estimates derived from blood pressure and sodium intake in different populations, and, if so, to estimate the impact of reducing dietary salt on mortality from stroke and ischaemic heart disease.
Analysis of the results of 68 crossover trials and 10 randomised controlled trials of dietary salt reduction.
Comparison of observed reductions in systolic blood pressure for each trial with predicted values calculated from between population analysis.
In the 45 trials in which salt reduction lasted four weeks or less the observed reductions in blood pressure were less than those predicted, with the difference between observed and predicted reductions being greatest in the trials of shortest duration. In the 33 trials lasting five weeks or longer the predicted reductions in individual trials closely matched a wide range of observed reductions. This applied for all age groups and for people with both high and normal levels of blood pressure. In people aged 50-59 years a reduction in daily sodium intake of 50 mmol (about 3 g of salt), attainable by moderate dietary salt reduction would, after a few weeks, lower systolic blood pressure by an average of 5 mm Hg, and by 7 mm Hg in those with high blood pressure (170 mm Hg); diastolic blood pressure would be lowered by about half as much. It is estimated that such a reduction in salt intake by a whole Western population would reduce the incidence of stroke by 22% and of ischaemic heart disease by 16% [corrected].
The results from the trials support the estimates from the observational data in the accompanying two papers. The effect of universal moderate dietary salt reduction on mortality from stroke and ischaemic heart disease would be substantial--larger, indeed, than could be achieved by fully implementing recommended policy for treating high blood pressure with drugs. However, reduction also in the amount of salt added to processed foods would lower blood pressure by at least twice as much and prevent some 75,000 [corrected] deaths a year in Britain as well as much disability.
确定饮食减盐试验中所实现的血压降低在数量上是否与从不同人群的血压和钠摄入量得出的估计值一致;如果是,则评估减少饮食盐分对中风和缺血性心脏病死亡率的影响。
对68项饮食减盐交叉试验和10项随机对照试验的结果进行分析。
将每项试验中观察到的收缩压降低值与根据人群间分析计算出的预测值进行比较。
在45项减盐持续四周或更短时间的试验中,观察到的血压降低幅度小于预测值,在持续时间最短的试验中,观察值与预测值之间的差异最大。在33项持续五周或更长时间的试验中,各试验的预测降低值与广泛的观察降低值密切匹配。这适用于所有年龄组以及血压高和正常的人群。在50 - 59岁的人群中,通过适度减少饮食盐分,每天钠摄入量减少50 mmol(约3克盐),几周后收缩压平均可降低5 mmHg,高血压患者(血压为170 mmHg)可降低7 mmHg;舒张压降低幅度约为收缩压的一半。据估计,整个西方人群如此减少盐摄入量将使中风发病率降低22%,缺血性心脏病发病率降低16%[校正后]。
试验结果支持随附的两篇论文中观察数据的估计。普遍适度减少饮食盐分对中风和缺血性心脏病死亡率的影响将是巨大的——实际上比通过全面实施推荐的药物治疗高血压政策所能达到的效果更大。然而,减少加工食品中的添加盐量也会使血压降低至少两倍,并在英国每年预防约75,000[校正后]例死亡以及许多残疾。